Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy
R Haas, R Kronenwett, G Sczakiel, A Hochhaus… - … in Hematopoietic Stem …, 1998 - Springer
The degree of tumor load reduction after therapy, which is determined by the degrees of
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …
Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy.
A Hochhaus, A Reiter, H Skladny… - Recent Results in …, 1998 - europepmc.org
The degree of tumor load reduction after therapy, which is determined by the degrees of
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …
Molecular Monitoring of Residual Disease in Chronic Myelogenous Leukemia Patients After Therapy
A Hochhaus, A Reiter, H Skladny, A Reichert… - … in Hematopoietic Stem …, 1998 - Springer
The degree of tumor load reduction after therapy, which is determined by the degrees of
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …
Molecular Monitoring of Residual Disease in Chronic Myelogenous Leukemia Patients After Therapy
A Hochhaus, A Reiter, H Skladny… - Advances in …, 2012 - books.google.com
The degree of tumor load reduction after therapy, which is determined by the degrees of
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …
[引用][C] Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy
A HOCHHAUS - Recet Results Cancer Res, 1998 - cir.nii.ac.jp
Molecular monitoring of residual disease in chronic myelogenous leukemia patients after
therapy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
therapy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy
A Hochhaus, A Reiter, H Skladny… - Recent results in …, 1998 - pubmed.ncbi.nlm.nih.gov
The degree of tumor load reduction after therapy, which is determined by the degrees of
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …
cytoreduction and cytogenetic response, is an important prognostic factor for patients with …